ClinicalTrials.Veeva

Menu

Comparison of SBRTand Repeat TACE for HCC (STH)

G

Gangneung Asan Hospital

Status

Unknown

Conditions

HepatoCellular Carcinoma

Treatments

Radiation: SBRT

Study type

Interventional

Funder types

Other

Identifiers

NCT03326375
GNH_RT-001

Details and patient eligibility

About

Comparison of Stereotactic Body Radiation Therapy (SBRT) and repeated transarterial chemoembolization (TACE) for Hepatocellular Carcinoma (HCC)as a Local Salvage Treatment after first incomplete TACE

Full description

The aim of this study is to evaluate the effect of SBRT after first incomplete TACE.

In HCC patients with incomplete TACE response, repeated TACE did not showed good response. In this case, SBRT could have better results than TACE.

Enrollment

80 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age >18 years
  • Eastern cooperative oncology group(ECOG) score 0 to 2
  • Primary HCC
  • HCC (single nodule ≤ 7 cm or max 3 nodules ≤ 3 cm)
  • Child-Turgottei-Pugh A or B
  • Unresectable lesion or medically contraindicated surgery or a case in which surgery was declined.
  • No evidence of radiologically definable major vascular invasion or extrahepatic disease
  • Previously incomplete TACE with radiologically defined residual disease after first TACE
  • Informed consent

Exclusion criteria

  • Prior TACE to the target lesion
  • Contraindication to receiving radiotherapy or TACE
  • Decompensated liver cirrhosis
  • Extrahepatic mets
  • Pregnancy
  • Patients with other cancers

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

80 participants in 2 patient groups

SBRT (Stereotatic body radiotherapy)
Experimental group
Description:
Treatment of SBRT in HCC patients who have incomplete response after first TACE
Treatment:
Radiation: SBRT
TACE (Transarterial chemoembolization)
No Intervention group
Description:
Treatment of repeated TACE in HCC patients who have incomplete response after first TACE

Trial contacts and locations

1

Loading...

Central trial contact

Baek Gyu Jun, M.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems